Spots Global Cancer Trial Database for Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer
Official Title: Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer
Study ID: NCT01322893
Conditions
Interventions
Study Description
Brief Summary: Women with metastatic breast cancer, receiving first line treatment of any kind (chemotherapy, endocrine treatment or treatment with antibodies) will be included in this trial. In connection to treatment, blood samples for determination and enumeration of circulating tumour cells will be collected at different time points. Serum and plasma will be collected and stored for future analysis of RNA and DNA.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Lund University Hospital, Lund, , Sweden
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
